Table 3.
Characteristics of the included studies.
| Study ID (Reference) | Scale(Franke l/ASIA) | Scale A (%) | Scale B (%) | Scale C (%) | Scale D (%) | Scale E (%) | Complete paraplegia (%) | Complete tetra plegia (%) | Incomplete paraplegia (%) | Incomplete tetraplegia (%) | Cervical | Thoracic | Lumbar/sac ral |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Al-Jadid et al., [14] | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Al-Jadid et al., [15] | - | - | - | - | - | - | - | - | - | - | 146 (31.33%) | 225 (48.28%) | 95 (20.4%) |
| Rahimi-Movaghar et al., [16] | - | - | - | - | - | - | 278 (56.04%) | 99 (19.9%) | 73 (14.71%) | 39 (7.86%) | - | - | - |
| Al-Habib et al., [17] | - | - | - | - | - | - | - | - | - | - | 9 (39%) | 11 (47.8%) | 109 (43.5%) |
| Tasoglu et al., [18] | ASIA | 93 (35.5%) | 43 (16%) | 56 (21.4%) | 69 (26.3%) | 1 (0.04%) | 76 (29%) | 16 (6.1%) | 117 (44.7%) | 53 (20.2%) | 69 (26.3%) | 121 (46.2%) | 72 (27.5%) |
| Derakhshanrad et al., [19] | ASIA | 608 (53.5%) | 203 (18.7%) | 200 (17.6%) | 109 (9.6%) | 7 (0.6%) | 496 (43.6%) | 115 (10.1)% | 308 (27.1%) | 218 (19.2%) | 358 (31.5%) | 658 (57.9%) | 121 (10.6%) |
| Gur et al., [20] | - | - | - | - | - | 243(45.08%) | 75 (13.91%) | 148 (27.48%) | 74 (13.72%) | cervical:137 (25.41%), thoracic:198 | |||
| Erhan et al., [21] | ASIA | 56 (55%) | 45 (45%) | - | - | - | - | 50 (47.2%) | 37 (34.9%) | 13 (12.3%) | |||
| Erdoǧan et al., [22] | ASIA | 65 (15.9%) | 344 (84.1%) | - | - | - | - | ||||||
| Mahmoud et al., [23] | ASIA | 261 (83.7%) | 25 (8.01%) | 26 (8.33%) | - | 239 (76.6%) | 73 (23.4%) | - | - | - | - | - | |
| Karamehmetoglul et al., [24] | - | - | - | - | - | - | 102 (67%) | 50 (33%) | - | - | 50 (33%) | - | 102 (67%) |
| Alfrayh et al., [25] | - | - | - | - | - | - | - | - | - | - | - | - | - |
| El Tallawy et al., [26] | ASIA | 1 (16.7%) | - | 1 (16.7%) | 4 (66.7%) | - | - | - | - | - | 3 (50%) | 1 (16.7%) | 2 (33.3%) |
| Movaghar et al., [27] | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Atci et al., [28] | - | - | - | - | - | - | - | - | - | - | 12(13.1%) | 56 (61.53%) | 23 (25.27%) |
| Karamehmetoglul et al., [29] | - | - | - | - | - | - | 44 (58.7%) | 31 (41.3%) | - | - | - | - | - |
| Dincer et al., [30] | - | - | - | - | - | - | 1442 (85.12%) | 82 (4.84%) | 116 (6.85%) | 54 (3.19%) | - | - | - |
| Karacan et al., [31] | - | - | - | - | - | - | 394 (67.8%) | 187 (32.18%) | - | - | 184 (31.7%) | 156 (26.6%) | 162 (27.8%) |
| Alshahri at al., [32] | - | - | - | - | - | - | 90 (29%) | 66 (22%) | 56 (18%) | 95 (31%) | - | - | - |
| Cosar et al., [33] | - | 94 (74%) | 18 (14.3%) | 8 (6.2%) | 7 (5.5%) | - | Tetra: 36 (28.3%) | Para: 76 (59.8%) | - | - | - | ||
| Taghippor et al., [34] | Frankel | 28 (32.94%) | 51 (60%) | - | - | - | - | - | - | - | - | ||
| Rahimi-Movaghar et al., [35] | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Chabok et al., [36] | - | - | - | - | - | - | 4 (9.1%) | 11 (25%) | 29 (65.9%) | - | - | - | |
| Otom et al., [37] | Frankel | 81 (53.6%) | 15 (10%) | 34 (22.5%) | 21 (13.9%) | - | - | - | - | - | 48 (31.8%) | 103 (68.2%) | |
| Raibulet et al., [38] | Frankel | 26 (29%) | 21 (22.7%) | 34 (38.3%) | 9 (9.9%) | - | - | - | - | - | - | - | - |
| Alshahri SS et al., [39] | - | - | - | - | - | - | 80 (37.03%) | 36 (16.66%) | 53 (24.53%) | 47 (21.75%) | - | - | - |
| Alhoseini et al., [40] | ASIA | 119 (86.2%) | 5 (3.6%) | 3 (2.2%) | 11 (8%) | - | Tetra: 25 (18.1%) | Para: 113 (81.9%) | - | - | - | ||
| Fakharian et al., [41] | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Quinones et al., [42] | - | - | - | - | - | - | 21 (28%) | 23 (30.7%) | 11 (14.7%) | 20 (26.6%) | 43 (57.3%) | 32 (42.66%) | |